• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Information (3190)
Event Date 10/24/2016
Event Type  Injury  
Manufacturer Narrative
The event related to the second valve used will be reported as a separate event.(b)(4) (3004478276-2016-00159).
 
Event Description
The manufacturer was notified on (b)(6) 2016 of the following: the surgeon attempted to implant a perceval with the guidance of a proctor.The first valve that was used, deployed low in position due to excessive force.The first valve was removed, a second perceval 25/l was used was malpositioned and deployed supra-annularly.The second perceval valve was removed and a mosaic size 27mm valve was used instead.
 
Manufacturer Narrative
The following were changed: device evaluated by mfr?, result code.
 
Event Description
Attempted to implant perceval with proctor guidance.Valve deployed subannularly.Additional details (nov 5 e-mail from sales): there did not appear to be any device related issues.He attempted to implant 2 valves but did not seat either one accurately.The first one deployed to low due to excessive force.The second deployed supra-annular.The valves used were: pvs25 sn (b)(4), pvs25 sn (b)(4).After explanting the second perceval, he decided to use a medtronic mosaic 27 tissue valve.The patient follow a normal post-op course without complication.Both of the valves listed above were shipped back to customer service in the us using the appropriate explant kits.Certainly this was not a device related issue, it was a technique issue.Additional info (nov 8 sales e-mail): my best guess would be that it added approximately 30 minutes to the cross clamp and pump time.I do know that the patient followed a normal postop course with no complications.Additional info (nov 10 sales e-mail): the surgeon was dr (b)(6) at (b)(6) hospital in (b)(6).
 
Manufacturer Narrative
Corrected data: corrected data, on supplemental medwatch #1 awareness date should have stated apr 6, 2017.(b)(4).Analysis: the complete manufacturing and material records for the perceval heart valve, model icv1210, s/n (b)(4), were pulled and reviewed by quality control at (b)(4).The results confirmed that this valve satisfied all material, visual, and performance standards required for a perceval heart valve at the time of manufacture and release.The gross examination was completed and results showed that the valve appeared to be in general good conditions.According to the current procedure at the time of release, the visual examination showed that there was no non conformities.No irregularities were found while performing the dimensional analysis.Based on the information that was provided, there was no device failure suspected or found during analysis.The event was a result of user technique during implantation where the device was malpositioned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
4125650
MDR Report Key6126453
MDR Text Key60844767
Report Number3004478276-2016-00158
Device Sequence Number1
Product Code DYE
UDI-Device Identifier00896208000436
UDI-Public(01)00896208000436(240)ICV1210(17)190602
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 05/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/23/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/02/2019
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/14/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received05/10/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-